674 related articles for article (PubMed ID: 29438696)
1. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
2. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
[TBL] [Abstract][Full Text] [Related]
3. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
Petrini I; Meltzer PS; Kim IK; Lucchi M; Park KS; Fontanini G; Gao J; Zucali PA; Calabrese F; Favaretto A; Rea F; Rodriguez-Canales J; Walker RL; Pineda M; Zhu YJ; Lau C; Killian KJ; Bilke S; Voeller D; Dakshanamurthy S; Wang Y; Giaccone G
Nat Genet; 2014 Aug; 46(8):844-9. PubMed ID: 24974848
[TBL] [Abstract][Full Text] [Related]
4. Molecular landscape of thymic epithelial tumors.
Prays J; Ortiz-Villalón C
Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
[TBL] [Abstract][Full Text] [Related]
5. A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.
He Y; Kim IK; Bian J; Polyzos A; Di Giammartino DC; Zhang YW; Luo J; Hernandez MO; Kedei N; Cam M; Borczuk AC; Lee T; Han Y; Conner EA; Wong M; Tillo DC; Umemura S; Chen V; Ruan L; White JB; Miranda IC; Awasthi PP; Altorki NK; Divakar P; Elemento O; Apostolou E; Giaccone G
J Thorac Oncol; 2022 Dec; 17(12):1375-1386. PubMed ID: 36049655
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
Elm L; Levidou G
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
[TBL] [Abstract][Full Text] [Related]
7. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
Yamada Y
Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
[TBL] [Abstract][Full Text] [Related]
8. Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
Ardeshir-Larijani F; Schneider BP; Althouse SK; Radovich M; Masood A; Perna F; Salman H; Loehrer PJ
JCO Precis Oncol; 2023 Feb; 7():e2200465. PubMed ID: 36787505
[TBL] [Abstract][Full Text] [Related]
9. Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
Bellissimo T; Ganci F; Gallo E; Sacconi A; Tito C; De Angelis L; Pulito C; Masciarelli S; Diso D; Anile M; Petrozza V; Giangaspero F; Pescarmona E; Facciolo F; Venuta F; Marino M; Blandino G; Fazi F
Mol Cancer; 2017 May; 16(1):88. PubMed ID: 28486946
[TBL] [Abstract][Full Text] [Related]
10. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
[TBL] [Abstract][Full Text] [Related]
12. Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
Maury JM; Merveilleux du Vignaux C; Drevet G; Zarza V; Chalabreysse L; Maisse C; Gineys B; Dolmazon C; Tronc F; Girard N; Leroux C
PLoS One; 2019; 14(3):e0197655. PubMed ID: 30897085
[TBL] [Abstract][Full Text] [Related]
13. Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas.
Hsieh MS; Kao HL; Huang WC; Wang SY; Lin SY; Chu PY; Pan CC; Chou TY; Ho HL; Yeh YC
Mod Pathol; 2023 Feb; 36(2):100008. PubMed ID: 36853782
[TBL] [Abstract][Full Text] [Related]
14.
Tarrini G; Ciabatti E; Pacini S; Galimberti S; Petrini I
Anticancer Res; 2017 Oct; 37(10):5459-5462. PubMed ID: 28982856
[TBL] [Abstract][Full Text] [Related]
15. Methylation and expression profiles of MGMT gene in thymic epithelial tumors.
Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A
Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682
[TBL] [Abstract][Full Text] [Related]
16. Genomic characterization of thymic epithelial tumors in a real-world dataset.
Kurokawa K; Shukuya T; Greenstein RA; Kaplan BG; Wakelee H; Ross JS; Miura K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
ESMO Open; 2023 Oct; 8(5):101627. PubMed ID: 37703595
[TBL] [Abstract][Full Text] [Related]
17. Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.
Lee HS; Jang HJ; Shah R; Yoon D; Hamaji M; Wald O; Lee JS; Sugarbaker DJ; Burt BM
Clin Cancer Res; 2017 Aug; 23(16):4855-4864. PubMed ID: 28400429
[No Abstract] [Full Text] [Related]
18. Thymic stroma and TFII-I: towards new targeted therapies.
Manti PG; Trattaro S; Castaldi D; Pezzali M; Spaggiari L; Testa G
Trends Mol Med; 2022 Jan; 28(1):67-78. PubMed ID: 34865984
[TBL] [Abstract][Full Text] [Related]
19. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells.
Iaiza A; Tito C; Ganci F; Sacconi A; Gallo E; Masciarelli S; Fontemaggi G; Fatica A; Melis E; Petrozza V; Venuta F; Marino M; Blandino G; Fazi F
Front Immunol; 2022; 13():867181. PubMed ID: 35529877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
